PBCC 2026 Washington, DC | A 2L Treatment Option for HR+/HER2- aBC or mBC with PIK3CA, AKT1, or PTEN Alterations Following Progression on or After ET +/- CDK4/6

Stay up to date on the latest for Perspectives In Breast Cancer Care by entering your email address below.

Disclaimer: Entering your email address here will automatically subscribe you to future email communications from MedscapeLIVE events. This does not qualify as a registration for the conference. Please follow the links for registration to ensure your spot for Perspectives In Breast Cancer Care.

Agenda